There was a nonsignificant trend for inferior outcomes with increased preceding therapy lines.
← all excerpts
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
1
—
—
There was a nonsignificant trend for inferior outcomes with increased preceding therapy lines.